⚲
|
Kynam Capital Management LP
✚
| |
---|---|
CRD # | 314368 |
SEC # | 801-126187 |
CIK # | 0001907884 |
AUM | $1.8 BB (2024-06-12) |
Employees | 3 (67% Investors, 0% Brokers) |
Phone | 574-315-9016 |
Address | 221 Elm Road Princeton, NJ 08540 |
Source | [IAPD] [EDGAR] |
Total AUM ($MM) |
---|
CIK | Period |
---|---|
0001907884 | |
/ |
Sector | Form 13F Holdings | Cap ($MM) | Value ($MM) |
---|---|---|---|
Natera Inc | 3,633.0 | 218.1 | |
Vertex Pharmaceuticals Inc / Ma | 70,632.1 | 154.7 | |
Celldex Therapeutics Inc | 1,341.4 | 125.4 | |
Syndax Pharmaceuticals Inc | 1,042.0 | 117.5 | |
Dynavax Technologies Corp | 1,537.2 | 79.5 | |
UNUM Therapeutics Inc | 567.1 | 78.1 | |
Insmed Inc | 2,379.6 | 67.0 | |
Vaxcyte Inc | 1,215.3 | 56.9 | |
Vera Therapeutics Inc | 360.7 | 55.8 | |
Biocryst Pharmaceuticals Inc | 1,941.2 | 54.5 | |
Protagonist Therapeutics Inc | 411.1 | 27.7 | |
2Seventy Bio Inc | 504.1 | 22.9 | |
Signal Genetics Inc | 293.2 | 22.8 | |
Wave Life Sciences Ltd | 220.3 | 19.8 | |
Desert Gateway Inc | 1,504.7 | 16.6 | |
Liquidia Corp | 281.8 | 11.0 | |
Ironwood Pharmaceuticals Inc | 1,773.8 | 10.7 | |
Alnylam Pharmaceuticals Inc | 17,179.7 | 10.4 | |
TYRA Biosciences Inc | 303.6 | 9.1 | |
Amarin Corp PLC UK | 734.5 | 8.4 | |
Sutro Biopharma Inc | 245.5 | 5.9 | |
Acelyrin Inc | 3.7 | ||
Caribou Biosciences Inc | 344.8 | 2.7 | |
CG Oncology Inc | 1.7 | ||
Prev | Page 1 | Next |
Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
---|---|---|---|---|
HF | Kynam Global Healthcare Master Fund LP | [2021-04-12] | 34.6 | 1,578.5 |
AUM Breakdown | Accounts | AUM ($MM) |
---|---|---|
By Client Type | ||
(a) Individuals (other than high net worth individuals) | 0 | 0.0 |
(b) Individuals (high net worth individuals) | 0 | 0.0 |
(c) Banking or thrift institutions | 0 | 0.0 |
(d) Investment companies | 0 | 0.0 |
(e) Business development companies | 0 | 0.0 |
(f) Pooled investment vehicles | 5 | 1,833.9 |
(g) Pension and profit sharing plans | 0 | 0.0 |
(h) Charitable organizations | 0 | 0.0 |
(i) State or municipal government entities | 0 | 0.0 |
(j) Other investment advisers | 0 | 0.0 |
(k) Insurance companies | 0 | 0.0 |
(l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
(m) Corporations or other businesses not listed above | 0 | 0.0 |
(n) Other | 0 | 0.0 |
Total | 5 | 1,833.9 |
By Discretionary | ||
Discretionary | 5 | 1,833.9 |
Non-Discretionary | 0 | 0.0 |
Total | 5 | 1,833.9 |
By Non-United States Persons | ||
Non-United States Persons | 1,088.9 | |
United States Persons | 745.0 | |
Total | 5 | 1,833.9 |
Form D Directors | # Filings | # Firms | 2011 - 2024 |
---|---|---|---|
Robert Meschi | 121 | ||
Richard Ruffer | 331 | ||
Yue Tang | 2 | ||
Kynam Capital Management LP | 2 |
EDGAR Form | CIK | 2011 - 2024 |
---|---|---|
13F-HR | [0001907884] | |
3 | [0001907884] | |
4 | [0001907884] | |
SC 13G | [0001907884] |
Form 3/4/5 Subject | 2011 - 2024 |
---|---|
2seventy bio, Inc. | |
Kynam Capital Management, LP |
Comparable Firms | State | AUM ($BB) |
---|---|---|
DLD Asset Management LP
✚
|
NY | 1.9 |
North Peak Capital Management LLC
✚
|
NY | 1.9 |
Madison Avenue Partners LP
✚
|
NY | 1.9 |
Broad Reach Investment Management LLP
✚
|
1.8 | |
Vestal Point Capital LP
✚
|
NY | 1.8 |
Jana Partners Management LP
✚
|
NY | 1.8 |
Electric Capital Partners LLC
✚
|
CA | 1.8 |
No Street GP LP
✚
|
CA | 1.8 |
Gladstone Capital Management LLP
✚
|
1.8 | |
Broad Bay Capital Management LP
✚
|
NY | 1.8 |